Agilon Health Ownership

AGL Stock  USD 1.89  0.11  6.18%   
The majority of agilon health outstanding shares are owned by other corporate entities. These outside corporations are usually referred to as non-private investors looking to acquire positions in agilon health to benefit from reduced commissions. Consequently, institutional investors are subject to a different set of regulations than regular investors in Agilon Health. Please pay attention to any change in the institutional holdings of agilon health as this could imply that something significant has changed or is about to change at the company.
 
Shares in Circulation  
First Issued
2018-12-31
Previous Quarter
411.3 M
Current Value
411.6 M
Avarage Shares Outstanding
394.3 M
Quarterly Volatility
21.2 M
 
Covid
Some institutional investors establish a significant position in stocks such as Agilon Health in order to find ways to drive up its value. Retail investors, on the other hand, need to know that institutional holders can own millions of shares of Agilon Health, and when they decide to sell, the stock will often sell-off, which may instantly impact shareholders' value. So, traders who get in early or near the beginning of the institutional investor's buying cycle could potentially generate profits.
The value of Dividends Paid is estimated to slide to about 5.5 M. The value of Dividend Paid And Capex Coverage Ratio is expected to slide to -5.32. Common Stock Shares Outstanding is expected to rise to about 439.7 M this year, although the value of Net Loss will most likely fall to (128.7 M).
Please note, institutional investors have a lot of resources and new technology at their disposal. They can put in a lot of research and financial analysis when reviewing investment options. There are many different types of institutional investors, including banks, hedge funds, insurance companies, and pension plans. One of the main advantages they have over retail investors is the fees paid for trades. As they are buying in large quantities, they can manage their cost more effectively.
  
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in agilon health. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price.
For more information on how to buy Agilon Stock please use our How to buy in Agilon Stock guide.

Agilon Stock Ownership Analysis

About 98.0% of the company shares are held by institutions such as insurance companies. The company has price-to-book (P/B) ratio of 1.35. Some equities with similar Price to Book (P/B) outperform the market in the long run. agilon health has Price/Earnings To Growth (PEG) ratio of 0.19. The entity recorded a loss per share of 0.76. The firm last dividend was issued on the February 17, 2016. Agilon Health had 2:1 split on the December 4, 1995. agilon health, inc. offers healthcare services for seniors through primary care physicians in the communities of the United States. The company was formerly known as Agilon Health Topco, Inc. and changed its name to agilon health, inc. in March 2021. agilon health, inc. was founded in 2016 and is based in Austin, Texas. Agilon Health operates under Medical Care Facilities classification in the United States and is traded on New York Stock Exchange. It employs 646 people. For more info on agilon health please contact Steven Sell at 562 256 3800 or go to https://www.agilonhealth.com.
Besides selling stocks to institutional investors, Agilon Health also allocates a substantial amount of its earnings to a pull of share-based compensation to be paid out to its employees, managers, executives, and members of the board of directors. Share-Based compensation (also sometimes called Stock-Based Compensation) is a way of paying different Agilon Health's stakeholders with equity in the business. It is typically used as a motivation factor for employees to contribute beyond their regular compensation (salary and bonus). It is also used as a tool to align Agilon Health's strategic interests with those of the company's shareholders. Shares issued to employees are usually subject to a vesting period before they are earned and sold.

Agilon Health Quarterly Liabilities And Stockholders Equity

2.09 Billion

Only 1.79% of agilon health are currently held by insiders. Unlike Agilon Health's institutional investors, corporate insiders most likely have a limit on the maximum percentage of share ownership. This is done to align insiders' influence against Agilon Health's private investors even though both sides will benefit from rising prices or experience loss when the share price declines. The good rule to have in mind is that the maximum share ownership percentage of the corporate insiders should not surpass 25%. View all of Agilon Health's insider trades

Agilon Stock Institutional Investors

Have you ever been surprised when a price of an equity instrument such as Agilon Health is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading agilon health backward and forwards among themselves. Agilon Health's institutional investor refers to the entity that pools money to purchase Agilon Health's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
Shares
Bank Of America Corp2024-06-30
4.8 M
Charles Schwab Investment Management Inc2024-09-30
M
Millennium Management Llc2024-06-30
2.8 M
Northern Trust Corp2024-09-30
2.6 M
Citadel Advisors Llc2024-09-30
2.1 M
Citigroup Inc2024-09-30
M
Deutsche Bank Ag2024-06-30
1.8 M
Tudor Investment Corp Et Al2024-09-30
1.5 M
Aqr Capital Management Llc2024-06-30
1.4 M
Morgan Stanley - Brokerage Accounts2024-06-30
112.8 M
Clayton Dubilier & Rice Llc2024-09-30
100 M
Note, although Agilon Health's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

agilon health Insider Trading Activities

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Agilon Health insiders, such as employees or executives, is commonly permitted as long as it does not rely on Agilon Health's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Agilon Health insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.

Agilon Health Outstanding Bonds

Agilon Health issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. agilon health uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Agilon bonds can be classified according to their maturity, which is the date when agilon health has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
When determining whether agilon health is a strong investment it is important to analyze Agilon Health's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Agilon Health's future performance. For an informed investment choice regarding Agilon Stock, refer to the following important reports:
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in agilon health. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price.
For more information on how to buy Agilon Stock please use our How to buy in Agilon Stock guide.
You can also try the Global Markets Map module to get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes.
Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Agilon Health. If investors know Agilon will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Agilon Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
11.951
Earnings Share
(0.76)
Revenue Per Share
13.717
Quarterly Revenue Growth
0.276
Return On Assets
(0.1)
The market value of agilon health is measured differently than its book value, which is the value of Agilon that is recorded on the company's balance sheet. Investors also form their own opinion of Agilon Health's value that differs from its market value or its book value, called intrinsic value, which is Agilon Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Agilon Health's market value can be influenced by many factors that don't directly affect Agilon Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Agilon Health's value and its price as these two are different measures arrived at by different means. Investors typically determine if Agilon Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Agilon Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.